Nutriband supports update to cdc opioid prescribing guidelines

New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications orlando, fl / accesswire / june 3, 2022 / nutriband inc. (nasdaq:ntrb) (nasdaq:ntrbw) supports the proposed update to the 2016 united states centers for disease control and prevention (cdc) guidelines for prescribing opioids for chronic pain and supports the cdc's recommendation to allow comprehensive and holistic pain management including responsible opioid use particularly for patients with moderate to severe chronic pain. the draft updated guidelines were posted for public comments earlier this year and the feedback has been overwhelmingly in favor of easing the restrictions on opioid prescribers to allow patients who can benefit from opioids to get the access they need while still employing risk mitigation strategies to reduce the abuse and misuse of opioids.
NTRB Ratings Summary
NTRB Quant Ranking